Drug Profile
Research programme: kinesin spindle protein inhibitors - Cytokinetics/GlaxoSmithKline
Alternative Names: GSK-295; KSPA-1Latest Information Update: 28 Jan 2009
Price :
$50
*
At a glance
- Originator Cytokinetics
- Developer Cytokinetics; GlaxoSmithKline
- Class Small molecules
- Mechanism of Action KIF11 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Sep 2008 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 01 Sep 2008 Interim pharmacokinetics data from a preclinical trial in Cancer presented at the 236th American Chemical Society National Meeting (236th-ACS-2008)
- 19 Jun 2008 Cytokinetics and GlaxoSmithKline extend their collaboration for a third time